Buchumschlag

Advances in targeting cutaneous melanoma

To date, the skin remains the most common cancer site among Caucasians in the western world. The complex, layered structure of human skin harbors a heterogenous population of specialized cells. Each cell type residing in the skin potentially gives rise to a variety of cancers, including non-melanoma...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kasakovski, Dimitri (VerfasserIn) , Skrygan, Marina (VerfasserIn) , Gambichler, Thilo (VerfasserIn) , Susok, Laura (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 26 April 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 9, Pages: 1-19
ISSN:2072-6694
DOI:10.3390/cancers13092090
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13092090
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/9/2090
Volltext
Verfasserangaben:Dimitri Kasakovski, Marina Skrygan, Thilo Gambichler and Laura Susok

MARC

LEADER 00000caa a2200000 c 4500
001 1772431915
003 DE-627
005 20230427055856.0
007 cr uuu---uuuuu
008 211005s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13092090  |2 doi 
035 |a (DE-627)1772431915 
035 |a (DE-599)KXP1772431915 
035 |a (OCoLC)1341421749 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kasakovski, Dimitri  |d 1994-  |e VerfasserIn  |0 (DE-588)1242511032  |0 (DE-627)1772431338  |4 aut 
245 1 0 |a Advances in targeting cutaneous melanoma  |c Dimitri Kasakovski, Marina Skrygan, Thilo Gambichler and Laura Susok 
264 1 |c 26 April 2021 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 05.10.2021 
520 |a To date, the skin remains the most common cancer site among Caucasians in the western world. The complex, layered structure of human skin harbors a heterogenous population of specialized cells. Each cell type residing in the skin potentially gives rise to a variety of cancers, including non-melanoma skin cancer, sarcoma, and cutaneous melanoma. Cutaneous melanoma is known to exacerbate and metastasize if not detected at an early stage, with mutant melanomas tending to acquire treatment resistance over time. The intricacy of melanoma thus necessitates diverse and patient-centered targeted treatment options. In addition to classical treatment through surgical intervention and radio- or chemotherapy, several systemic and intratumoral immunomodulators, pharmacological agents (e.g., targeted therapies), and oncolytic viruses are trialed or have been recently approved. Moreover, utilizing combinations of immune checkpoint blockade with targeted, oncolytic, or anti-angiogenic approaches for patients with advanced disease progression are promising approaches currently under pre-clinical and clinical investigation. In this review, we summarize the current ‘state-of-the-art’ as well as discuss emerging agents and regimens in cutaneous melanoma treatment. 
650 4 |a cancer therapy 
650 4 |a combination therapy 
650 4 |a immunotherapy 
650 4 |a intratumoral therapy 
650 4 |a melanoma 
650 4 |a skin cancer 
650 4 |a targeted therapy 
700 1 |a Skrygan, Marina  |e VerfasserIn  |4 aut 
700 1 |a Gambichler, Thilo  |e VerfasserIn  |4 aut 
700 1 |a Susok, Laura  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021), 9, Artikel-ID 2090, Seite 1-19  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Advances in targeting cutaneous melanoma 
773 1 8 |g volume:13  |g year:2021  |g number:9  |g elocationid:2090  |g pages:1-19  |g extent:19  |a Advances in targeting cutaneous melanoma 
856 4 0 |u https://doi.org/10.3390/cancers13092090  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/13/9/2090  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20211005 
993 |a Article 
994 |a 2021 
998 |g 1242511032  |a Kasakovski, Dimitri  |m 1242511032:Kasakovski, Dimitri  |d 60000  |d 65000  |e 60000PK1242511032  |e 65000PK1242511032  |k 0/60000/  |k 1/60000/65000/  |p 1  |x j 
999 |a KXP-PPN1772431915  |e 3984571097 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"roleDisplay":"VerfasserIn","display":"Kasakovski, Dimitri","family":"Kasakovski","role":"aut","given":"Dimitri"},{"display":"Skrygan, Marina","family":"Skrygan","roleDisplay":"VerfasserIn","given":"Marina","role":"aut"},{"role":"aut","given":"Thilo","display":"Gambichler, Thilo","family":"Gambichler","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Susok","display":"Susok, Laura","given":"Laura","role":"aut"}],"title":[{"title_sort":"Advances in targeting cutaneous melanoma","title":"Advances in targeting cutaneous melanoma"}],"note":["Gesehen am 05.10.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"19 S."}],"id":{"doi":["10.3390/cancers13092090"],"eki":["1772431915"]},"language":["eng"],"recId":"1772431915","relHost":[{"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel"}],"pubHistory":["1.2009 -"],"disp":"Advances in targeting cutaneous melanomaCancers","part":{"year":"2021","issue":"9","extent":"19","text":"13(2021), 9, Artikel-ID 2090, Seite 1-19","volume":"13","pages":"1-19"},"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"id":{"eki":["614095670"],"issn":["2072-6694"],"zdb":["2527080-1"]},"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"614095670","note":["Gesehen am 27.05.2020"],"title":[{"title":"Cancers","title_sort":"Cancers"}],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"name":{"displayForm":["Dimitri Kasakovski, Marina Skrygan, Thilo Gambichler and Laura Susok"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"26 April 2021"}]} 
SRT |a KASAKOVSKIADVANCESIN2620 

Ähnliche Einträge